论文部分内容阅读
Chronic hepatitis C virus (HCV) infection affects 80-160million people worldwide and is one of the leadingcauses of chronic liver disease. It is only a few yearsago that standard treatment regimes were based onpegylated interferon alpha and ribavirin. How